Filter
54
Text search:
Astra
Zeneca
Featured
Recommendations
10
New Publications
1
Language
Document type
Fact sheets
15
Studies & Reports
11
Guidelines
9
No document type
9
Resource Platforms
6
Situation Updates
2
Strategic & Response Plan
2
Countries / Regions
East and Southern Africa
4
India
3
West and Central Africa
3
Global
3
South Sudan
2
Germany
2
Kenya
2
Ukraine
2
Western and Central Europe
2
Congo, Democratic Republic of
1
South Africa
1
Brazil
1
Colombia
1
El Salvador
1
Chile
1
South–East Asia Region
1
Paraguay
1
Africa
1
Russia
1
South Korea
1
Authors & Publishers
Publication Years
Category
Countries
20
Public Health
3
Clinical Guidelines
3
Annual Report MEDBOX
1
Key Resources
1
Toolboxes
COVID-19
32
NCDs
8
Mental Health
7
Rapid Response
1
Caregiver
1
NTDs
1
Health Financing Toolbox
1
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group o
...
временное руководство. Первый выпуск: 10 февраля 2021 г. Обновлено: 21 апреля 2021 г. Последнее обновление 30 июля 2021г.
Comment The Lancet Volume 397, ISSUE 10269, P72-74, January 09, 2021
Published:December 08, 2020DOI:https://doi.org/10.1016/S0140-6736(20)32623-4
On the 9 February 2021, Africa CDC convened a special session of the Africa Task Force for COVID-19 to review existing data and evidence and recommend
On the 9 February 2021, Africa CDC convened a special session of the Africa Task Force for COVID-19 to review existing data and evidence and recommend
An overview of COVID-19 Vaccine AstraZeneca and why it is authorised in the EU. Available in 22 languages
18 Febr. 2021
New England Journal of Medicine
April 9, 2021
DOI: 10.1056/NEJMoa2104840
10 May 2021. Manufactureres:
SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])]
Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant)]
The ChAdOx1-S/nCoV-19 [recombinant] vaccine is a replication-deficient adenoviral vecto
...
orientations provisoires, première publication: 10 février 2021, mise à jour : 21 avril 2021, dernière mise à jour : 30 juillet 2021
7 April 2021
Based on current information, a causal relationship between the vaccine and the occurrence of blood clots with low platelets is considered plausible but is not confirmed.
Available in Englisch, French and Russian
REG 174 INFORMATION FOR UK HEALTHCARE PROFESSIONALS
Vaccines
recommended
COVID Reference 23 May 2021
